PORTFOLIO

Oral delivery platform for biopharmaceuticals.
Lead product completed phase II for ulcerative colitis and Crohn's disease.

Pharmaceutical company implementing novel concepts for the treatment of mental disorders.
Lead product in phase II for depression.

Marine biotechnology company developing new biologically active products from marine microbes.
Lead product in optimization for MRSA.

Advanced high-throughput R&D for new drugs and biofuels together with revenue generating services and tools business.

Brain-targeted drug delivery company, which uses its platform technologies to synergize with established and marketed drugs.
Lead product in optimization for the treatment of brain tumors.

Next generation antibody company developing improved therapeutic antibodies and antibody fragments based on its unique Modular Antibody Technology.

Medical device company developing an affordable, high-quality and patient-friendly retina camera for screening of diabetic patients. Three other eye diagnostic camera's in late stage development.

Development of novel biotechnology products for acute and chronic inflammatory diseases. Leader in the field of protein-glycan interactions (driving a number of inflammatory as well as many other pathological processes)

Developing an Enzyme replacement therapy for Morbus Morquio.
Lead product in manufacturing.